Suffolk Capital Management’s Gilead Sciences GILD Stock Holding History

Suffolk Capital Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-51,196	Closed	-$5.45M	–	138
2014 Q3	$5.45M	Sell	51,196 -1,004	-2%	-$98.3K	0.68%	58
2014 Q2	$4.33M	Buy	+52,200	New	+$4.06M	0.52%	62
2014 Q1	–	Sell	-136,850	Closed	-$10.3M	–	141
2013 Q4	$10.3M	Buy	+136,850	New	+$9.53M	1.29%	29
2013 Q3	–	Sell	-50,800	Closed	-$2.6M	–	146
2013 Q2	$2.6M	Buy	+50,800	New	+$2.65M	0.38%	86

Other funds holding GILD

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Suffolk Capital Management's GILD Position: Q4 2014 in Review

Suffolk Capital Management sold out of Gilead Sciences (GILD) in Q4 2014, closing a stake of 51,196 shares — an estimated $5.45M sold.

Suffolk Capital Management first reported a position in GILD in Q2 2013 and held it in 4 quarters. The position peaked at $10.3M in Q4 2013. 1,438 funds tracked by Wall St. Rank hold GILD as of Q4 2014.

Suffolk Capital Management reported no remaining Gilead Sciences position as of Q4 2014 after selling out during the quarter.
Suffolk Capital Management sold 51,196 Gilead Sciences shares in Q4 2014, an estimated $5.45M.
Suffolk Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 4 quarters.
Suffolk Capital Management's Gilead Sciences position peaked at $10.3M in Q4 2013.
1,438 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2014.

Based on Suffolk Capital Management's 13F filing for Q4 2014, filed 11 Feb 2015.